C
Carol Sawka
Researcher at University of Toronto
Publications - 84
Citations - 7890
Carol Sawka is an academic researcher from University of Toronto. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 36, co-authored 83 publications receiving 7083 citations. Previous affiliations of Carol Sawka include Cancer Care Ontario & Women's College, Kolkata.
Papers
More filters
Journal ArticleDOI
Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study.
TL;DR: Zidovudine and moderate-dose-interferon alfa may be combined safely for the treatment of HIV-associated KS, and both response to treatment and toxicity are dose related.
Journal ArticleDOI
Quality improvement in cancer symptom assessment and control: the Provincial Palliative Care Integration Project (PPCIP).
Julie Gilbert,Julie Gilbert,Doris Howell,Susan King,Carol Sawka,Carol Sawka,Erin Hughes,Helen Angus,Deborah Dudgeon,Deborah Dudgeon +9 more
TL;DR: It is demonstrated that significant strides in symptom screening and response can be achieved within a year using rapid-cycle change and collaborative approaches, and showed that both short- and long-term improvement require ongoing facilitation to embed the changes in system design and change the culture of clinical practice.
Journal ArticleDOI
An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer
M. Crump,Carol Sawka,Gerrit DeBoer,Roger B. Buchanan,James N. Ingle,John F. Forbes,J. William Meakin,W Shelley,Kathleen I. Pritchard +8 more
TL;DR: The efficacy of tamoxifen appears to be similar to that of ovarian ablation by surgery or irradiation as first-line therapy for premenopausal, ER positive metastatic breast cancer, and is unlikely to be substantially inferior.
Journal Article
Breast cancer survival by teaching status of the initial treating hospital
TL;DR: Women with node-negative breast cancer and tumours less than or equal to 20 mm in diameter who were initial seen at a teaching hospital had significantly better survival than women with similar tumours who were initially seen atA community hospital.
Journal Article
Patterns of initial management of node-negative breast cancer in two Canadian provinces
TL;DR: Lower patient age, smaller tumour size, a noncentral unifocal tumour, absence of extensive ductal carcinoma in situ and initial surgery by a surgeon with an academic affiliation were associated with greater use of BCS in both provinces.